Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-104-5 | CAS number: 66069-34-9
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.58 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 129 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No long term inhalation study is available therefore route to route extrapolation has been used.
- AF for dose response relationship:
- 1
- Justification:
- This is a default assessment factor for using the NOAEL as the result. This assessment factor was used based on guidance documents released by the ECHA.
- AF for differences in duration of exposure:
- 2
- Justification:
- Default assessment factor based upon the ECHAs guidance. In this case the assessment factor is 2 as we have a 6 month dog study which is classed as a sub-chronic study.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- This has been set to a default value of 1 as the inter species variability has already been looked into while calculating the modified dose descriptor.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor used, the value was obtained from guidance documents released by the ECHA
- AF for intraspecies differences:
- 5
- Justification:
- This is the default assessment factor for looking into intraspecies differences, this assessment factor was obtained from ECHA's guidance and is applicable just for workers.
- AF for the quality of the whole database:
- 2
- Justification:
- A klimisch reliability of 2 was assigned to the study based on the klimisch reliability scale (the reason a reliability of 2 was used is due to read across). This assessment factor has been based upon guidance documents from the ECHA. The reason we are using an assessment factor of 2 is due to the use of read across.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties, therefore a default assessment factor of 1 can be used.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 70
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- route to route extrapolation has been used as we have no long term data available via the dermal route of exposure
- AF for dose response relationship:
- 1
- Justification:
- This is a default assessment factor for using the NOAEL as the result. This assessment factor was used based on guidance documents released by the ECHA.
- AF for differences in duration of exposure:
- 2
- Justification:
- Default assessment factor based upon the ECHAs guidance. In this case the assessment factor is 2 as we have a 6 month dog study which is classed as a sub-chronic study.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- default assessment factor based on allometric scaling for dogs
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor used, the value was obtained from guidance documents released by the ECHA
- AF for intraspecies differences:
- 5
- Justification:
- This is the default assessment factor for looking into intraspecies differences, this assessment factor was obtained from ECHA's guidance and is applicable just for workers.
- AF for the quality of the whole database:
- 2
- Justification:
- A klimisch reliability of 2 was assigned to the study based on the klimisch reliability scale (the reason a reliability of 2 was used is due to read across). This assessment factor has been based upon guidance documents from the ECHA. The reason we are using an assessment factor of 2 is due to the use of read across.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties, therefore a default assessment factor of 1 can be used.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
DNEL for workers:
Systemic long term Inhalation DNEL:
Respiratory uptake is anticipated to be unlikely, it doesn't seem pertinent given particle size.
The Mass Median Aerodynamic Diameter has been shown to be 32.724µm and 6.90% of the substance was seen to be in the typical respirable dust range < 10.00 μm. In view of the physical nature of the test item, its apparent low volatility and its’ tendency to clump, it is considered unlikely to represent a significant hazard by the inhalation route.
It should be proposed that the inhalatory absorption value should be 10% on account of the particle size. For the sake of calculation, the inhalatory absorption should not however be considered less than the assumed oral absorption to avoid magnification of the corrected NOAEC, and as such for the purposes of this calculation 50% has been assumed to give a more protective/conservative value.
It is also worthy of note that the point of departure of 50 mg/kg/day is a minimum NOAEL. No higher dose level was selected for testing. Therefore the actual NOAEL may be equal to or greater than 50 mg/kg/day.
The 8h Respiratory Volume was calculated using a value referenced from a European Medicines Agency guidance document which states that the beagle respiratory volume was 9000 L/day, their reported weight was 11.5kg. Using these values a daily respiratory volume can be calculated to be 0.7826m3/kg bw/d and thus the 8h RV = 0.26 m3/kg bw.
Using the equation from guidance document R.8 example B.3 :
corrected inhalatory NOAEC = 50 x (1/0.26) x (50/50) x (6.7/10) = 129mg/m3
therefore DNEL = 129 / ( 1 x 2 x 1 x 2.5 x 5 x 2 x 1 ) = 129 / 50 = 2.58 mg/m3
Inhalation - Systemic acute:
The material is not classified for acute effects, therefore derivation of acute DNEL is not required. Long term DNELs are considered sufficient to ensure acute effects do not occur.
Inhalation - Local long term:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Inhalation - Local acute:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Dermal:
Systemic long term:
NOAEL calculated as described in guidance R.8 example B.5 assuming 50% and 50% absorption via oral and dermal routes respectively. The above assessment factors were used to calculate a DNEL of 0.2 mg/kg bw
Dermal - Systemic acute:
The material is not classified for acute effects, therefore derivation of acute DNEL is not required. Long term DNELs are considered sufficient to ensure acute effects do not occur.
Dermal - Local effects - long term:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Dermal - Local effects - acute:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Hazard for the eyes - Local effects:
The substance is not classified for eye irritation and therefore the DNEL has not been calculated.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.64 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 64 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No long term inhalation study is available therefore route to route extrapolation has been used.
- AF for dose response relationship:
- 1
- Justification:
- This is a default assessment factor for using the NOAEL as the result. This assessment factor was used based on guidance documents released by the ECHA.
- AF for differences in duration of exposure:
- 2
- Justification:
- Default assessment factor based upon the ECHAs guidance. In this case the assessment factor is 2 as we have a 6 month dog study which is classed as a sub-chronic study.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- This has been set to a default value of 1 as the inter species variability has already been looked into while calculating the modified dose descriptor.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor used, the value was obtained from guidance documents released by the ECHA
- AF for intraspecies differences:
- 10
- Justification:
- This is the default assessment factor for the general population, this value has been obtained from the ECHA's guidance documents.
- AF for the quality of the whole database:
- 2
- Justification:
- A klimisch reliability of 2 was assigned to the study based on the klimisch reliability scale (the reason a reliability of 2 was used is due to read across). This assessment factor has been based upon guidance documents from the ECHA. The reason we are using an assessment factor of 2 is due to the use of read across.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties, therefore a default assessment factor of 1 can be used.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.36 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 140
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- route to route extrapolation has been used as we have no long term data available via the dermal route of exposure
- AF for dose response relationship:
- 1
- Justification:
- This is a default assessment factor for using the NOAEL as the result. This assessment factor was used based on guidance documents released by the ECHA.
- AF for differences in duration of exposure:
- 2
- Justification:
- Default assessment factor based upon the ECHAs guidance. In this case the assessment factor is 2 as we have a 6 month dog study which is classed as a sub-chronic study.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- default assessment factor based on allometric scaling for dogs
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor used, the value was obtained from guidance documents released by the ECHA
- AF for intraspecies differences:
- 10
- Justification:
- This is the default assessment factor for the general population, this value has been obtained from the ECHA's guidance documents.
- AF for the quality of the whole database:
- 2
- Justification:
- A klimisch reliability of 2 was assigned to the study based on the klimisch reliability scale (the reason a reliability of 2 was used is due to read across). This assessment factor has been based upon guidance documents from the ECHA. The reason we are using an assessment factor of 2 is due to the use of read across.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties, therefore a default assessment factor of 1 can be used.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.36 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 140
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Route to route extrapolation was not required as we have a long term
- AF for dose response relationship:
- 1
- Justification:
- This is a default assessment factor for using the NOAEL as the result. This assessment factor was used based on guidance documents released by the ECHA.
- AF for differences in duration of exposure:
- 2
- Justification:
- Default assessment factor based upon the ECHAs guidance. In this case the assessment factor is 2 as we have a 6 month dog study which is classed as a sub-chronic study.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- default assessment factor based on allometric scaling for dogs
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor used, the value was obtained from guidance documents released by the ECHA
- AF for intraspecies differences:
- 10
- Justification:
- This is the default assessment factor for the general population, this value has been obtained from the ECHA's guidance documents.
- AF for the quality of the whole database:
- 2
- Justification:
- A klimisch reliability of 2 was assigned to the study based on the klimisch reliability scale (the reason a reliability of 2 was used is due to read across). This assessment factor has been based upon guidance documents from the ECHA. The reason we are using an assessment factor of 2 is due to the use of read across.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties, therefore a default assessment factor of 1 can be used.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
DNEL for general public:
Inhalation:
Inhalation - Systemic long term
Respiratory uptake is anticipated to be unlikely, it doesn't seem pertinent given particle size.
The Mass Median Aerodynamic Diameter has been shown to be 32.724µm and 6.90% of the substance was seen to be in the typical respirable dust range < 10.00 μm. In view of the physical nature of the test item, its apparent low volatility and its’ tendency to clump, it is considered unlikely to represent a significant hazard by the inhalation route.
It should be proposed that the inhalatory absorption value should be 10% on account of the particle size. For the sake of calculation, the inhalatory absorption should not however be considered less than the assumed oral absorption to avoid magnification of the corrected NOAEC, and as such for the purposes of this calculation 50% has been assumed to give a more protective/conservative value.
It is also worthy of note that the point of departure of 50 mg/kg/day is a minimum NOAEL. No higher dose level was selected for testing. Therefore the actual NOAEL may be equal to or greater than 50 mg/kg/day.
The 8h Respiratory Volume was calculated using a value referenced from a European Medicines Agency guidance document which states that the beagle respiratory volume was 9000 L/day, their reported weight was 11.5kg. Using these values a daily respiratory volume can be calculated to be 0.7826m3/kg bw/d and thus the 24h RV = 0.78 m3/kg bw.
Using the equation from guidance document R.8 example B.3 :
corrected inhalatory NOAEC = 50 x (1/0.78) x (50/50) = 64 mg/m3
Therefore DNEL = 64 / ( 1 x 2 x 1 x 2.5 x 10 x 2 x 1 ) = 64 / 100 = 2.58 mg/m3
Inhalation - Systemic acute:
The material is not classified for acute effects, therefore derivation of acute DNEL is not required. Long term DNELs are considered sufficient to ensure acute effects do not occur.
Inhalation - Local long term:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Inhalation - Local acute:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Dermal:
Dermal - Systemic long term:
NOAEL calculated as described in guidance R.8 example 8.5 assuming 50% and 50% absorption via oral and dermal routes respectively. The above assessment factors were used to calculate a DNEL of 0.36 mg/kg bw.
Dermal - Systemic acute:
The material is not classified for acute effects, therefore derivation of acute DNEL is not required. Long term DNELs are considered sufficient to ensure acute effects do not occur.
Dermal - Local effects - long term:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Dermal - Local effects - acute:
The test item is not a skin sensitiser, skin irritant or eye irritant, therefore the DNEL for local effects is not required.
Oral
Oral - systemic - long term:
The NOAEL was provided by a 6 month dog study. The above assessment factors were used to provide a final DNEL of 0.36 mg/kg/bw/day.
Oral - Systemic - acute effects:
The material is not classified for acute systemic effects, therefore derivation of acute DNEL is not required. Long term DNELs are considered sufficient to ensure acute effects do not occur.
Hazard for the eyes - Local effects:
The substance is not classified for eye irritation and therefore the DNEL has not been calculated.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
